1. A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
- Author
-
Apoorv Prasad, Gage Hurlburt, Seth Kingree, Sanjiti Podury, Medha Tandon, and Shitiz Sriwastava
- Subjects
Pediatrics ,medicine.medical_specialty ,BFP ,Neurosciences. Biological psychiatry. Neuropsychiatry ,GBS ,Cerebrospinal fluid ,medicine ,Demyelinating Disorder ,Internal medicine ,Paresis ,Guillain-Barre syndrome ,business.industry ,SARS-CoV-2 ,Diplegia ,medicine.disease ,Interesting Images ,RC31-1245 ,Vaccination ,medicine.anatomical_structure ,Peripheral nervous system ,Medicine ,Neurology (clinical) ,medicine.symptom ,Complication ,business ,COVID-19 vaccine ,RC321-571 - Abstract
Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. Antecedent infection or vaccine administration are known to precipitate the onset of this disorder. Its typical presentation leads to a symmetric, rapidly progressive, ascending paresis with associated sensory deficits and impaired reflexes. We present a rare case of a bi-facial diplegia variant of GBS, within four weeks of the COVID-19 vaccination. Due to its chronology, clinical manifestations, and cerebrospinal fluid (CSF) findings, we propose this case to be a rare complication of the COVID-19 vaccination.
- Published
- 2021